{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-066418","form_type":"8-K","ticker":"GRDX","cik":"0001604191","company_name":"GridAI Technologies Corp.","filed_at":"2025-07-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.470726+00:00","generated_at":"2026-05-18T09:05:25.937282+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Entero Therapeutics regains Nasdaq annual meeting compliance","bullets":["Received Nasdaq letter confirming compliance with Listing Rule 5620(a) after holding Annual Meeting on June 30, 2025.","Matter is now closed; no further action required from Nasdaq.","Company had previously reported the meeting in a Form 8-K filed July 2, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-066418","json":"https://secwatch.observer/filing/0001104659-25-066418.json","markdown":"https://secwatch.observer/filing/0001104659-25-066418.md","text":"https://secwatch.observer/filing/0001104659-25-066418.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925066418/0001104659-25-066418-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1604191/000110465925066418/tm2520095d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:05:25.937282+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}